Cargando…

Antivirals/interferon-α-1b: Elevated aminotransferases and vomiting following off-label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160397/ http://dx.doi.org/10.1007/s40278-021-96445-8

Ejemplares similares

Hydroxychloroquine: Elevated aminotransferase levels following off-label use: case report
Publicado: (2021)

Lopinavir/ritonavir: Nausea and vomiting following off label use: case report
Publicado: (2021)

Lopinavir/ritonavir/umifenovir: Nausea, vomiting and diarrhoea following off-label treatment: case report
Publicado: (2021)

Antivirals/glucocorticoids: Diabetes mellitus and ALT elevation following off-label use in COVID-19: case report
Publicado: (2020)

Remdesivir: Elevated aspartate aminotransferase and alanine aminotransferase levels: case report
Publicado: (2022)

Remdesivir/methylprednisolone/convalescent-anti-SARS-CoV-2-plasma: Elevated aminotransferase levels and off-label use: case report
Publicado: (2021)

Entecavir/interferon-α-2b/methylprednisolone: Hepatitis B viral reactivation and off label use: case report
Publicado: (2021)

Hydroxychloroquine/lopinavir/ritonavir: Vomiting and QTc-interval prolongation following off-label therapy: 2 case reports
Publicado: (2021)

Lopinavir/ritonavir/oseltamivir/warfarin interaction: Increase in the INR and alanine aminotransferase following off label use: 10 case reports
Publicado: (2020)

Antivirals: Repolarisation and conduction disorder following off-label use: 2 case reports
Publicado: (2021)

Antivirals/fluoroquinolones: Prolongation of QTc interval following off-label use: 9 case reports
Publicado: (2021)

Tocilizumab: Elevated AST and ALT following off label therapy: 11 case reports
Publicado: (2021)

Azithromycin/hydroxychloroquine: Elevated liver enzymes following off label use: case report
Publicado: (2020)

Isolated elevated aspartate aminotransferase in an asymptomatic woman due to macro-aspartate aminotransferase: A case report
por: Zhan, Meng-Ru, et al.
Publicado: (2019)

Lopinavir/ritonavir/immune globulin/interferon-α: Lack of efficacy during off-label treatment: case report
Publicado: (2021)

Dipyrone/interferon-β-1b interactions: Haematological toxicity following drug interactions and off-label use: case report
Publicado: (2021)

Remdesivir: Elevated AST and ALT levels following off-label therapy: 4 case reports
Publicado: (2020)

Baricitinib/methylprednisolone/prednisolone: Elevated HBV DNA following an off label use: case report
Publicado: (2022)

Baricitinib/dexamethasone: Myalgia and elevated creatine kinase following an off-label use: case report
Publicado: (2022)

Antibacterials/interferon/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Antibacterials/antivirals: Erythema multiforme and off label use: 2 case reports
Publicado: (2020)

Antivirals/immunosuppressants: COVID-19 infection and off label use: case report
Publicado: (2020)

Antibacterials/antivirals: QTc-interval prolongation and cardiac arrest following off-label therapy: 3 case reports
Publicado: (2021)

Multiple drugs: Elevated INR and off-label use: case report
Publicado: (2022)

Favipiravir: Fever and elevated uric acid level following off-label therapy: 2 case reports
Publicado: (2021)

Remdesivir: Elevated ALT level and lack of efficacy following off-label use: 13 case reports
Publicado: (2021)

Interferon-alpha-2b/oseltamivir/umifenovir: Worsening of liver function impairment following exposure to off label drugs in pregnancy: case report
Publicado: (2020)

Multiple drugs: Elevated alanine transaminase and off label use: case report
Publicado: (2020)

Baricitinib/lopinavir/ritonavir: Elevated transaminases and off-label use: case report
Publicado: (2020)

Azithromycin: Elevated transaminase levels during off-label treatment: case report
Publicado: (2021)

Hydroxychloroquine: Myopathy with elevated creatine kinase and creatine kinase-MB following off-label use: case report
Publicado: (2021)

Multiple drugs: Mucormycosis following off-label use, elevated serum creatinine and hypokalaemia: 6 case reports
Publicado: (2022)

Ciclosporin/interferon-beta-1a: Various toxicities and off-label use: case report
Publicado: (2022)

Hydroxychloroquine: Hepatotoxicity following off-label treatment: case report
Publicado: (2020)

Hydroxychloroquine: Rash following off label use: case report
Publicado: (2020)

Hydroxychloroquine: Haemolysis following off-label use: case report
Publicado: (2021)

Methylprednisolone: Bacteraemia following off label use: case report
Publicado: (2021)

Ceftriaxone: Cholelithiasis following off-label use: case report
Publicado: (2021)

Hydroxychloroquine: Eosinophilia following off-label use: case report
Publicado: (2021)

Tocilizumab: Anaphylaxis following off-label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4bs37ee97landrbib8rtbaiqo4